Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Specialty Devices
Drug Delivery Devices
Return to: MDBR Home | Specialty Devices | Drug Delivery Devices | News
Search Refinements

Drug Delivery Devices News

View news from other Medical Devices sectors:
46-60 of 555 results
Cook Medical launches Zilver PTX drug-eluting peripheral stent thumbwheel delivery system in France
Cook Medical has launched Zilver PTX drug-eluting peripheral stent thumbwheel delivery system in France.
Specialty Devices > Drug Delivery Devices > News
FDA approves six-month primary end point for Lutonix below-the-knee drug coated balloon
C. R. Bard announced the US Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE) supplemental application to modify the primary endpoint to a six-month time point for the Lutonix 014 Drug Coated Balloon PTA Catheter (DCB).
Specialty Devices > Drug Delivery Devices > News
QT Vascular gets FDA IDE approval to begin Chocolate Touch drug-coated balloon trial
By MDBR Staff Writer
QT Vascular has secured conditional investigational device exemption (IDE) approval from the US Food and Drug Administration to begin the pivotal study of its new Chocolate Touch drug-coated balloon.
Specialty Devices > Drug Delivery Devices > News
FDA approves Medtronic’s IN.PACT Admiral DCB to treat in-stent restenosis
By MDBR Staff Writer
Medtronic has secured approval from the US Food and Drug Administration (FDA) for its IN.PACT Admiral drug-coated balloon (DCB) to treat in-stent restenosis (ISR) in patients with peripheral artery disease (PAD).
Specialty Devices > Drug Delivery Devices > News
Ablative gets FDA nod for phase 2 trial of combination drug/device therapy for hypertension
By MDBR Staff Writer
The US Food and Drug Administration has given its approval for Ablative Solutions to begin phase II trial of combination drug/device therapy for hypertension.
Specialty Devices > Drug Delivery Devices > News
Novo Nordisk recalls six batches of GlucaGen HypoKit due to detached needles on syringe
Novo Nordisk is recalling six batches of the GlucaGen HypoKit in the U.S. due to two customer complaints from the UK and Portugal involving detached needles on the syringe with Sterile Water for Injection (SWFI).
Specialty Devices > Drug Delivery Devices > News
PharmaJet collaborates with World Health Organization
PharmaJet announced a multi-year agreement with the World Health Organization to provide PharmaJet’s Needle-free technology to be used in the global effort to eradicate polio.
Specialty Devices > Drug Delivery Devices > News
Taris begins second Phase 1b clinical trial of Gemcitabine releasing intravesical system
By MDBR Staff Writer
Taris Biomedical has started the second Phase Ib clinical trial of the Gemcitabine releasing intravesical system (GemRIS or TAR-200) with non-muscle-invasive bladder cancer (NMIBC) patients.
Specialty Devices > Drug Delivery Devices > News
Allergan to buy eye care firm ForSight VISION5 for $95m
By MDBR Staff Writer
Ireland-based Allergan has signed an agreement to acquire eye care company ForSight VISION5 for around $95m.
Specialty Devices > Drug Delivery Devices > News
Spectranetics wins CE mark approval for AngioSculptX drug-coated balloon catheter
By MDBR Staff Writer
Medical devices manufacturer Spectranetics has received CE mark approval for its AngioSculptX drug-coated PTCA scoring balloon catheter.
Specialty Devices > Drug Delivery Devices > News
Solo Technology to launch new connected device to fight prescription drug abuse
By MDBR Staff Writer
Solo Technology Holdings is set to introduce iKeyp, a new connected device intended at fighting prescription drug theft and abuse.
Specialty Devices > Drug Delivery Devices > News
BTG announces successful CE mark reclassification for DC Bead
BTG, a global specialist healthcare company, announced that it has obtained European Conformity (CE) Mark from the Notified Body British Standards Institution (BSI) following completion of the reclassification of DC Bead and DC BeadM1 as Class III medical devices under Rule 8 of Annex IX to Directive 93/42/EEC.
Specialty Devices > Drug Delivery Devices > News
BioCorRx signs license deal with TheraKine for new injectable naltrexone technology
By MDBR Staff Writer
BioCorRx has signed a license agreement with TheraKine to develop a new injectable naltrexone technology.
Specialty Devices > Drug Delivery Devices > News
Fresenius Kabi introduces six presentations of Magnesium Sulfate in ready-to-administer Freeflex bags
Fresenius Kabi announced that it has introduced six presentations of Magnesium Sulfate in convenient, ready-to-administer Freeflex bags.
Specialty Devices > Drug Delivery Devices > News
46-60 of 555 results